Cooper Financial Group’s Boston Scientific BSX Stock Holding History

Cooper Financial Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,566	Closed	-$1.01M	–	431
2025 Q4	$1.01M	Sell	10,566 -561	-5%	-$55K	0.11%	141
2025 Q3	$1.09M	Buy	11,127 +2,750	+33%	+$285K	0.12%	132
2025 Q2	$900K	Buy	8,377 +5,654	+208%	+$572K	0.11%	155
2025 Q1	$275K	Buy	+2,723	New	+$274K	0.04%	320

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cooper Financial Group's BSX Position: Q1 2026 in Review

Cooper Financial Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 10,566 shares — an estimated $1.01M sold.

Cooper Financial Group first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $1.09M in Q3 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Cooper Financial Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Cooper Financial Group sold 10,566 Boston Scientific shares in Q1 2026, an estimated $1.01M.
Cooper Financial Group first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
Cooper Financial Group's Boston Scientific position peaked at $1.09M in Q3 2025.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Cooper Financial Group's 13F filing for Q1 2026, filed 7 Apr 2026.